3 Things You Should Know About Advancing mCRPC Care: Targeted Sequencing, Epigenetics, and Emerging Strategies.
| Publicado en: | Oncology (08909091) Vol. 39; no. 5; pp. 208 - 212 |
|---|---|
| Autores principales: | , , |
| Formato: | CEU exam questions tables/charts Journal Article |
| Publicado: |
MJH Life Sciences
Jun2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=186034870&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 186034870 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 08909091 YYT jtl: Oncology (08909091) issn: 08909091 maglogo: N pubinfo: dt: Jun2025 vid: 39 iid: 5 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 186034870 186034870 186034870 186034870 ppf: 208 ppct: 4 formats: fmt: @attributes: type: P tig: atl: 3 Things You Should Know About Advancing mCRPC Care: Targeted Sequencing, Epigenetics, and Emerging Strategies. aug: au: Agarwal, Neeraj Beltran, Himisha Hussain, Maha affil: Professor of Medicine, University of Utah, Salt Lake City, UT sug: subj: Epigenomics Prostatic Neoplasms, Castration-Resistant Drug Therapy Oncologic Care Neuroendocrine Tumors Prostatic Neoplasms Nuclear Proteins Prostate-Specific Membrane Antigen Disease Progression Antineoplastic Agents, Combined Therapeutic Use Education, Continuing (Credit) pubtype: Academic Journal doctype: CEU exam questions tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|